Inagaki J, Rodriguez V, Bodey GP. Proceedings: causes of death in
cancer patients. Cancer.1974
;33(2):568
-573.
2.
Kern KA, Norton JA. Cancer cachexia. JPEN J Parenter
Enteral Nutr.1988
;12(3):286
-298.
3.
Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss
prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.
Am J Med.1980
;69(4):491
-497.
4.
Bosaeus I, Daneryd P, Svanberg E, Lundholm K. Dietary intake and
resting energy expenditure in relation to weight loss in unselected cancer
patients. Int J Cancer.2001
;93(3):380
-383.
5.
Bosaeus I, Daneryd P, Lundholm K. Dietary intake, resting energy
expenditure, weight loss and survival in cancer patients. J
Nutr. 2002;132(11 suppl): 3465S-3466S.
6.
Puccio M, Nathanson L. The cancer cachexia syndrome.
Semin Oncol.1997
;24(3):277
-287.
7.
Ottery FD. Supportive nutrition to prevent cachexia and improve
quality of life. Semin Oncol.1995
;22(2 suppl 3):98
-111.
8.
Bozzetti F. Rationale and indications for preoperative feeding of
malnourished surgical cancer patients. Nutrition.2002
;18(11-12):953
-959.
9.
Koretz RL. Do data support nutrition support? Part I: intravenous
nutrition. J Am Diet Assoc.2007
;107(6):988
-996; quiz 998.
10.
McGeer A, Detsky A, O'Rourke K. Parenteral nutrition in cancer
patients undergoing chemotherapy: a meta-analysis.
Nutrition.1990
;6(3):233
-240.
11.
Goldstein SA, Elwyn DH, Askanazi J. Functional and metabolic
changes during feeding in gastrointestinal cancer. J Am Coll
Nutr.1989
;8(6):530
-536.
12.
Torosian MH. Stimulation of tumor growth by nutrition support.
JPEN J Parenter Enteral Nutr.1992
;16(6 suppl):72S
-75S.
13.
Baron PL, Lawrence W Jr, Chan WM, White FK, Banks WL Jr. Effects of
parenteral nutrition on cell cycle kinetics of head and neck cancer.
Arch Surg.1986
;121(11):1282
-1286.
14.
Frank JL, Lawrence W Jr, Banks WL Jr, McKinnon JG, Chan WM, Collins
JM. Modulation of cell cycle kinetics in human cancer with total parenteral
nutrition. Cancer.1992
;69(7):1858
-1864.
15.
Franchi F, Rossi-Fanelli F, Seminara P, Cascino A, Barone C,
Scucchi L. Cell kinetics of gastrointestinal tumors after different
nutritional regimens. A preliminary report. J Clin
Gastroenterol.1991
;13(3):313
-315.
16.
Heys SD, Park KG, McNurlan MA, et al. Stimulation of protein
synthesis in human tumours by parenteral nutrition: evidence for modulation of
tumour growth. Br J Surg.1991
;78(4):483
-487.
17.
Bozzetti F, Gavazzi C, Mariani L, Crippa F. Glucose-based total
parenteral nutrition does not stimulate glucose uptake by humans tumours.
Clin Nutr.2004
;23(3):417
-421.
18.
Pacelli F, Bossola M, Teodori L, et al. Parenteral nutrition does
not stimulate tumor proliferation in malnourished gastric cancer patients.
JPEN J Parenter Enteral Nutr.2007
;31(6):451
-455.
19.
A.S.P.E.N. Board of Directors. Guidelines for use of total
parenteral nutrition in the hospitalized adult patient. JPEN J
Parenter Enteral Nutr.1986
;10(5):441
-445.
20.
A.S.P.E.N. Board of Directors. Guidelines for the use of parenteral
and enteral nutrition in adult and pediatric patients. JPEN J
Parenter Enteral Nutr.1993
;17(4 suppl):1SA
-52SA.
21.
A.S.P.E.N. Board of Directors and The Clinical Guidelines Task
Force. Guidelines for the use of parenteral and enteral nutrition in adult and
pediatric patients [erratum in JPEN 2002;26(2):144]. JPEN
J Parenter Enteral Nutr.2002
;26(1 suppl):1SA
-138SA.
22.
Committee to Advise the Public Health Service on Clinical Practice
Guidelines, Institute of Medicine. Field MJ, Lohr KN, eds. Clinical
Practice Guidelines: Directions for a New Program. Washington,
DC: The National Academies Press; 1990:58
.
23.
Seres D, Compher C, Seidner D, Byham-Gray L, Gervasio J, McClave S.
2005 American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)
Standards and Guidelines survey. Nutr Clin Pract.2006
;21(5):529
-532.
24.
Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign
guidelines for management of severe sepsis and septic shock. Crit
Care Med.2004
;32(3):858
-873.
25.
Guyatt GH, Haynes RB, Jaeschke RZ, et al. for the Evidence-Based
Medicine Working Group. Users' Guides to the Medical Literature: XXV.
Evidence-based medicine: principles for applying the Users' Guides to patient
care. JAMA.2000
;284(10):1290
-1296.
26.
Bauer J, Capra S. Comparison of a malnutrition screening tool with
subjective global assessment in hospitalised patients with
cancer—sensitivity and specificity. Asia Pac J Clin
Nutr. 2003;12
(3):257
-260.
27.
Bauer J, Capra S, Ferguson M. Use of the scored Patient-Generated
Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in
patients with cancer. Eur J Clin Nutr.2002
; 56(8):779
-785.
28.
Read JA, Crockett N, Volker DH, et al. Nutritional assessment in
cancer: comparing the Mini-Nutritional Assessment (MNA) with the scored
Patient-Generated Subjective Global Assessment (PGSGA). Nutr
Cancer.2005
;53(1):51
-56.
29.
Sarhill N, Mahmoud F, Walsh D, et al. Evaluation of nutritional
status in advanced metastatic cancer. Support Care
Cancer. 2003;11
(10):652
-659.
30.
Sungurtekin H, Sungurtekin U, Hanci V, Erdem E. Comparison of two
nutrition assessment techniques in hospitalized patients.
Nutrition.2004
;20(5):428
-432.
31.
Unsal D, Mentes B, Akmansu M, Uner A, Oguz M, Pak Y. Evaluation of
nutritional status in cancer patients receiving radiotherapy: a prospective
study. Am J Clin Oncol.2006
;29(2):183
-188.
32.
van Bokhorst-de van der Schueren MA, van Leeuwen PA, Sauerwein HP,
Kuik DJ, Snow GB, Quak JJ. Assessment of malnutrition parameters in head and
neck cancer and their relation to postoperative complications. Head
Neck.1997
;19(5):419
-425.
33.
Murry DJ, Riva L, Poplack DG. Impact of nutrition on
pharmacokinetics of anti-neoplastic agents. Int J Cancer
Suppl. 1998;11:48
-51.
34.
Hammerlid E, Wirblad B, Sandin C, et al. Malnutrition and food
intake in relation to quality of life in head and neck cancer patients.
Head Neck.1998
;20(6):540
-548.
35.
Isenring E, Bauer J, Capra S. The effect of intensive dietetic
intervention on nutritional status of hospitalized patients on chemotherapy.
Nutrition and Dietetics.2004
;61:46
-49.
36.
Isenring E, Capra S, Bauer J. Patient satisfaction is rated higher
by radiation oncology outpatients receiving nutrition intervention compared
with usual care. J Hum Nutr Diet.2004
;17(2):145
-152.
37.
Piquet MA, Ozsahin M, Larpin I, et al. Early nutritional
intervention in oropharyngeal cancer patients undergoing radiotherapy.
Support Care Cancer.2002
;10(6):502
-504.
38.
Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Dietary
counseling improves patient outcomes: a prospective, randomized, controlled
trial in colorectal cancer patients undergoing radiotherapy. J Clin
Oncol.2005
;23(7):1431
-1438.
39.
Ferguson ML, Bauer J, Gallagher B, Capra S, Christie DR, Mason BR.
Validation of a malnutrition screening tool for patients receiving
radiotherapy. Australas Radiol.1999
;43(3):325
-327.
40.
Isenring E, Cross G, Daniels L, Kellett E, Koczwara B. Validity of
the malnutrition screening tool as an effective predictor of nutritional risk
in oncology outpatients receiving chemotherapy. Support Care
Cancer.2006
;14(11):1152
-1156.
41.
Holter AR, Fischer JE. The effects of perioperative
hyperalimentation on complications in patients with carcinoma and weight loss.
J Surg Res.1977
;23(1):31
-34.
42.
Sako K, Lore JM, Kaufman S, Razack MS, Bakamjian V, Reese P.
Parenteral hyperalimentation in surgical patients with head and neck cancer: a
randomized study. J Surg Oncol.1981
;16(4):391
-402.
43.
Muller JM, Brenner U, Dienst C, Pichlmaier H. Preoperative
parenteral feeding in patients with gastrointestinal carcinoma.
Lancet.1982
;1(8263):68
-71.
44.
Yamada N, Koyama H, Hioki K, Yamada T, Yamamoto M. Effect of
postoperative total parenteral nutrition (TPN) as an adjunct to gastrectomy
for advanced gastric carcinoma. Br J Surg.1983
;70(5):267
-274.
45.
Muller JM, Keller HW, Brenner U, Walter M, Holzmuller W.
Indications and effects of preoperative parenteral nutrition. World
J Surg.1986
;10(1):53
-63.
46.
Perioperative total parenteral nutrition in surgical patients. The
Veterans Affairs Total Parenteral Nutrition Cooperative Study Group.
N Engl J Med.1991
;325(8):525
-532.
47.
Brennan MF, Pisters PW, Posner M, Quesada O, Shike M. A prospective
randomized trial of total parenteral nutrition after major pancreatic
resection for malignancy. Ann Surg.1994
;220(4):436
-441; discussion 441-434.
48.
Fan ST, Lo CM, Lai EC, Chu KM, Liu CL, Wong J. Perioperative
nutritional support in patients undergoing hepatectomy for hepatocellular
carcinoma. N Engl J Med.1994
;331(23):1547
-1552.
49.
Bozzetti F, Gavazzi C, Miceli R, et al. Perioperative total
parenteral nutrition in malnourished, gastrointestinal cancer patients: a
randomized, clinical trial. JPEN J Parenter Enteral
Nutr.2000
;24(1):7
-14.
50.
Hyltander A, Bosaeus I, Svedlund J, et al. Supportive nutrition on
recovery of metabolism, nutritional state, health-related quality of life, and
exercise capacity after major surgery: a randomized study. Clin
Gastroenterol Hepatol.2005
;3(5):466
-474.
51.
Wu GH, Liu ZH, Wu ZH, Wu ZG. Perioperative artificial nutrition in
malnourished gastrointestinal cancer patients. World J
Gastroenterol.2006
;12(15):2441
-2444.
52.
Meijerink WJ, von Meyenfeldt MF, Rouflart MM, Soeters PB. Efficacy
of perioperative nutritional support. Lancet.1992
; 340(8812):187
-188.
53.
Gianotti L, Braga M, Vignali A, et al. Effect of route of delivery
and formulation of postoperative nutritional support in patients undergoing
major operations for malignant neoplasms. Arch Surg.1997
;132(11):1222
-1229; discussion 1229-1230.
54.
Sand J, Luostarinen M, Matikainen M. Enteral or parenteral feeding
after total gastrectomy: prospective randomised pilot study. Eur J
Surg.1997
;163(10):761
-766.
55.
Shirabe K, Matsumata T, Shimada M, et al. A comparison of
parenteral hyperalimentation and early enteral feeding regarding systemic
immunity after major hepatic resection—the results of a randomized
prospective study. Hepatogastroenterology.1997
;44(13):205
-209.
56.
Braga M, Gianotti L, Gentilini O, Parisi V, Salis C, Di Carlo V.
Early postoperative enteral nutrition improves gut oxygenation and reduces
costs compared with total parenteral nutrition. Crit Care
Med.2001
;29(2):242
-248.
57.
Bozzetti F, Braga M, Gianotti L, Gavazzi C, Mariani L.
Postoperative enteral versus parenteral nutrition in malnourished patients
with gastrointestinal cancer: a randomised multicentre trial.
Lancet.2001
;358(9292):1487
-1492.
58.
Aiko S, Yoshizumi Y, Sugiura Y, et al. Beneficial effects of
immediate enteral nutrition after esophageal cancer surgery. Surg
Today.2001
;31(11):971
-978.
59.
Papapietro K, Diaz E, Csendes A, et al. Early enteral nutrition in
cancer patients subjected to a total gastrectomy. Rev Med
Chil.2002
;130(10):1125
-1130.
60.
Jiang XH, Li N, Li JS. Intestinal permeability in patients after
surgical trauma and effect of enteral nutrition versus parenteral nutrition.
World J Gastroenterol.2003
;9(8):1878
-1880.
61.
Aiko S, Yoshizumi Y, Matsuyama T, Sugiura Y, Maehara T. Influences
of thoracic duct blockage on early enteral nutrition for patients who
underwent esophageal cancer surgery. Jpn J Thorac Cardiovasc
Surg.2003
;51(7):263
-271.
62.
Hu QG, Zheng QC. The influence of enteral nutrition in
postoperative patients with poor liver function. World J
Gastroenterol.2003
;9(4):843
-846.
63.
Goonetilleke KS, Siriwardena AK. Systematic review of perioperative
nutritional supplementation in patients undergoing pancreaticoduodenectomy.
JOP.2006
;7(1):5
-13.
64.
Hyltander A, Drott C, Unsgaard B, et al. The effect on body
composition and exercise performance of home parenteral nutrition when given
as adjunct to chemotherapy of testicular carcinoma. Eur J Clin
Invest.1991
;21(4):413
-420.
65.
Sagar S, Harland P, Shields R. Early postoperative feeding with
elemental diet. Br Med J.1979
;1(6159):293
-295.
66.
Smith RC, Hartemink RJ, Hollinshead JW, Gillett DJ. Fine bore
jejunostomy feeding following major abdominal surgery: a controlled randomized
clinical trial. Br J Surg.1985
;72(6):458
-461.
67.
Foschi D, Cavagna G, Callioni F, Morandi E, Rovati V.
Hyperalimentation of jaundiced patients on percutaneous transhepatic biliary
drainage. Br J Surg.1986
;73(9):716
-719.
68.
Heslin MJ, Latkany L, Leung D, et al. A prospective, randomized
trial of early enteral feeding after resection of upper gastrointestinal
malignancy. Ann Surg.1997
;226(4):567
-577; discussion 577-580.
69.
Seven H, Calis AB, Turgut S. A randomized controlled trial of early
oral feeding in laryngectomized patients.
Laryngoscope. 2003;113
(6):1076
-1079.
70.
Jordan WM, Valdivieso M, Frankmann C, et al. Treatment of advanced
adenocarcinoma of the lung with ftorafur, doxorubicin, cyclophosphamide, and
cisplatin (FACP) and intensive iv hyperalimentation. Cancer Treat
Rep.1981
;65(3-4):197
-205.
71.
Nixon D, Moffitt S, Lawson D, et al. Total parenteral nutrition as
an adjunct to chemotherapy for metastatic colorectal cancer. Cancer
Treatment Reports.1981
;65(suppl 5):123
-128.
72.
Popp MB, Fisher RI, Wesley R, Aamodt R, Brennan MF. A prospective
randomized study of adjuvant parenteral nutrition in the treatment of advanced
diffuse lymphoma: influence on survival. Surgery.1981
;90(2):195
-203.
73.
Samuels ML, Selig DE, Ogden S, Grant C, Brown B. Iv
hyperalimentation and chemotherapy for stage III testicular cancer: a
randomized study. Cancer Treat Rep.1981
;65(7-8):615
-627.
74.
Serrou B, Cupissol D, Plagne R, et al. Follow-up of a randomized
trial for oat cell carcinoma evaluating the efficacy of peripheral intravenous
nutrition (PIVN) as adjunct treatment. Recent Results Cancer
Res. 1982;80:246
-253.
75.
Shamberger RC, Brennan MF, Goodgame JT Jr, et al. A prospective,
randomized study of adjuvant parenteral nutrition in the treatment of
sarcomas: results of metabolic and survival studies.
Surgery.1984
;96(1):1
-13.
76.
Tandon SP, Gupta SC, Sinha SN, Naithani YP. Nutritional support as
an adjunct therapy of advanced cancer patients. Indian J Med
Res. 1984;80:180
-188.
77.
Clamon GH, Feld R, Evans WK, et al. Effect of adjuvant central IV
hyperalimentation on the survival and response to treatment of patients with
small cell lung cancer: a randomized trial. Cancer Treat
Rep.1985
;69(2):167
-177.
78.
Valdivieso M, Frankmann C, Murphy WK, et al. Long-term effects of
intravenous hyperalimentation administered during intensive chemotherapy for
small cell bronchogenic carcinoma. Cancer.1987
;59(2):362
-369.
79.
Evans WK, Nixon DW, Daly JM, et al. A randomized study of oral
nutritional support versus ad lib nutritional intake during chemotherapy for
advanced colorectal and non-small-cell lung cancer. J Clin
Oncol.1987
;5(1):113
-124.
80.
De Cicco M, Panarello G, Fantin D, et al. Parenteral nutrition in
cancer patients receiving chemotherapy: effects on toxicity and nutritional
status. JPEN J Parenter Enteral Nutr.1993
;17(6):513
-518.
81.
Bozzetti F, Cozzaglio L, Gavazzi C, et al. Nutritional support in
patients with cancer of the esophagus: impact on nutritional status, patient
compliance to therapy, and survival. Tumori.1998
;84(6):681
-686.
82.
Jin D, Phillips M, Byles JE. Effects of parenteral nutrition
support and chemotherapy on the phasic composition of tumor cells in
gastrointestinal cancer. JPEN J Parenter Enteral Nutr.1999
;23(4):237
-241.
83.
Beer KT, Krause KB, Zuercher T, Stanga Z. Early percutaneous
endoscopic gastrostomy insertion maintains nutritional state in patients with
aerodigestive tract cancer. Nutr Cancer.2005
; 52(1):29
-34.
84.
Mangar S, Slevin N, Mais K, Sykes A. Evaluating predictive factors
for determining enteral nutrition in patients receiving radical radiotherapy
for head and neck cancer: a retrospective review. Radiother
Oncol.2006
;78(2):152
-158.
85.
Rabinovitch R, Grant B, Berkey BA, et al. Impact of nutrition
support on treatment outcome in patients with locally advanced head and neck
squamous cell cancer treated with definitive radiotherapy: a secondary
analysis of RTOG trial 90-03. Head Neck.2006
;28(4):287
-296.
86.
Scolapio JS, Tarrosa VB, Stoner GL, Moreno-Aspitia A, Solberg LA
Jr, Atkinson EJ. Audit of nutrition support for hematopoietic stem cell
transplantation at a single institution. Mayo Clin
Proc.2002
;77(7):654
-659.
87.
Gavazzi C, Bhoori S, Lovullo S, Cozzi G, Mariani L. Role of home
parenteral nutrition in chronic radiation enteritis. Am J
Gastroenterol.2006
;101(2):374
-379.
88.
Bachmann P, Marti-Massoud C, Blanc-Vincent MP, et al. Summary
version of the Standards, Options and Recommendations for palliative or
terminal nutrition in adults with progressive cancer (2001). Br J
Cancer. 2003;89(suppl 1): S107-S110.
89.
Abu-Rustum NR, Barakat RR, Venkatraman E, Spriggs D. Chemotherapy
and total parenteral nutrition for advanced ovarian cancer with bowel
obstruction. Gynecol Oncol.1997
;64(3):493
-495.
90.
August DA, Thorn D, Fisher RL, Welchek CM. Home parenteral
nutrition for patients with inoperable malignant bowel obstruction.
JPEN J Parenter Enteral Nutr.1991
;15(3):323
-327.
91.
King LA, Carson LF, Konstantinides N, et al. Outcome assessment of
home parenteral nutrition in patients with gynecologic malignancies: what have
we learned in a decade of experience? Gynecol Oncol.1993
;51(3):377
-382.
92.
Lundholm K, Daneryd P, Bosaeus I, Korner U, Lindholm E. Palliative
nutritional intervention in addition to cyclooxygenase and erythropoietin
treatment for patients with malignant disease: effects on survival,
metabolism, and function. Cancer. 2004;100
(9):1967
-1977.
93.
McCann RM, Hall WJ, Groth-Juncker A. Comfort care for terminally
ill patients: the appropriate use of nutrition and hydration.
JAMA.1994
;272(16):1263
-1266.
94.
Orrevall Y, Tishelman C, Permert J. Home parenteral nutrition: a
qualitative interview study of the experiences of advanced cancer patients and
their families. Clin Nutr.2005
;24(6):961
-970.
95.
Scolapio JS, Fleming CR, Kelly DG, Wick DM, Zinsmeister AR.
Survival of home parenteral nutrition-treated patients: 20 years of experience
at the Mayo Clinic. Mayo Clin Proc.1999
;74(3):217
-222.
96.
Brard L, Weitzen S, Strubel-Lagan SL, et al. The effect of total
parenteral nutrition on the survival of terminally ill ovarian cancer
patients. Gynecol Oncol.2006
;103(1):176
-180.
97.
Mirhosseini N, Fainsinger RL, Baracos V. Parenteral nutrition in
advanced cancer: indications and clinical practice guidelines. J
Palliat Med.2005
;8(5):914
-918.
98.
Baines M, Oliver DJ, Carter RL. Medical management of intestinal
obstruction in patients with advanced malignant disease: a clinical and
pathological study. Lancet.1985
;2(8462):990
-993.
99.
Welk TA. Clinical and ethical considerations of fluid and
electrolyte management in the terminally ill client. J Intraven
Nurs.1999
;22(1):43
-47.
100.
Jho DH, Cole SM, Lee EM, Espat NJ. Role of omega-3 fatty acid
supplementation in inflammation and malignancy. Integr Cancer
Ther.2004
;3(2):98
-111.
101.
Hardman WE. Omega-3 fatty acids to augment cancer therapy.
J Nutr.2002
;132(11 suppl):3508S
-3512S.
102.
Wigmore SJ, Ross JA, Falconer JS, et al. The effect of
polyunsaturated fatty acids on the progress of cachexia in patients with
pancreatic cancer. Nutrition.1996
;12(1 suppl):S27
-S30.
103.
Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC,
Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E
restore immunodeficiency and prolong survival for severely ill patients with
generalized malignancy: a randomized control trial.
Cancer.1998
;82(2):395
-402.
104.
Burns CP, Halabi S, Clamon GH, et al. Phase I clinical study of
fish oil fatty acid capsules for patients with cancer cachexia: cancer and
leukemia group B study 9473. Clin Cancer Res.1999
;5(12):3942
-3947.
105.
Wigmore SJ, Barber MD, Ross JA, Tisdale MJ, Fearon KC. Effect of
oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.
Nutr Cancer.2000
;36(2):177
-184.
106.
Bruera E, Strasser F, Palmer JL, et al. Effect of fish oil on
appetite and other symptoms in patients with advanced cancer and
anorexia/cachexia: a double-blind, placebo-controlled study. J Clin
Oncol.2003
;21(1):129
-134.
107.
Gogos CA, Ginopoulos P, Zoumbos NC, Apostolidou E, Kalfarentzos F.
The effect of dietary omega-3 polyunsaturated fatty acids on T-lymphocyte
subsets of patients with solid tumors. Cancer Detect
Prev.1995
;19(5):415
-417.
108.
Barber MD, Ross JA, Preston T, Shenkin A, Fearon KC. Fish
oil-enriched nutritional supplement attenuates progression of the acute-phase
response in weight-losing patients with advanced pancreatic cancer.
J Nutr.1999
;129(6):1120
-1125.
109.
Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KC. The effect of
an oral nutritional supplement enriched with fish oil on weight-loss in
patients with pancreatic cancer. Br J Cancer.1999
;81(1):80
-86.
110.
Barber MD, Fearon KC, Tisdale MJ, McMillan DC, Ross JA. Effect of a
fish oil-enriched nutritional supplement on metabolic mediators in patients
with pancreatic cancer cachexia. Nutr Cancer.2001
;40(2):118
-124.
111.
Bauer J, Capra S, Battistutta D, Davidson W, Ash S. Compliance with
nutrition prescription improves outcomes in patients with unresectable
pancreatic cancer. Clin Nutr.2005
;24(6):998
-1004.
112.
Fearon KC, Von Meyenfeldt MF, Moses AG, et al. Effect of a protein
and energy dense N-3 fatty acid enriched oral supplement on loss of weight and
lean tissue in cancer cachexia: a randomised double blind trial.
Gut.2003
;52(10):1479
-1486.
113.
Jatoi A, Rowland K, Loprinzi CL, et al. An eicosapentaenoic acid
supplement versus megestrol acetate versus both for patients with
cancer-associated wasting: a North Central Cancer Treatment Group and National
Cancer Institute of Canada collaborative effort. J Clin
Oncol.2004
;22(12):2469
-2476.
114.
Mantovani G, Madeddu C, Maccio A, et al. Cancer-related
anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond
current treatment. Cancer Epidemiol Biomarkers Prev.2004
;13(10):1651
-1659.
115.
de Luis DA, Izaola O, Aller R, Cuellar L, Terroba MC. A randomized
clinical trial with oral Immunonutrition (omega3-enhanced formula vs.
arginine-enhanced formula) in ambulatory head and neck cancer patients.
Ann Nutr Metab.2005
;49(2):95
-99.
116.
Moses AW, Slater C, Preston T, Barber MD, Fearon KC. Reduced total
energy expenditure and physical activity in cachectic patients with pancreatic
cancer can be modulated by an energy and protein dense oral supplement
enriched with n-3 fatty acids. Br J Cancer.2004
;90(5):996
-1002.
117.
Persson C, Glimelius B, Ronnelid J, Nygren P. Impact of fish oil
and melatonin on cachexia in patients with advanced gastrointestinal cancer: a
randomized pilot study. Nutrition.2005
;21(2):170
-178.
118.
Carter JP, Saxe GP, Newbold V, Peres CE, Campeau RJ, Bernal-Green
L. Hypothesis: dietary management may improve survival from nutritionally
linked cancers based on analysis of representative cases. J Am Coll
Nutr.1993
;12(3):209
-226.
119.
Gonzalez NJ, Isaacs LL. Evaluation of pancreatic proteolytic enzyme
treatment of adenocarcinoma of the pancreas, with nutrition and detoxification
support. Nutr Cancer.1999
;33(2):117
-124.
120.
Hildenbrand GL, Hildenbrand LC, Bradford K, Cavin SW. Five-year
survival rates of melanoma patients treated by diet therapy after the manner
of Gerson: a retrospective review. Altern Ther Health
Med.1995
;1(4):29
-37.
121.
Braga M, Gianotti L, Vignali A, Carlo VD. Preoperative oral
arginine and n-3 fatty acid supplementation improves the immunometabolic host
response and outcome after colorectal resection for cancer.
Surgery.2002
;132(5):805
-814.
122.
Braga M, Gianotti L, Vignali A, Cestari A, Bisagni P, Di Carlo V.
Artificial nutrition after major abdominal surgery: impact of route of
administration and composition of the diet. Crit Care
Med.1998
;26(1):24
-30.
123.
Daly JM, Lieberman MD, Goldfine J, et al. Enteral nutrition with
supplemental arginine, RNA, and omega-3 fatty acids in patients after
operation: immunologic, metabolic, and clinical outcome.
Surgery.1992
;112(1):56
-67.
124.
Daly JM, Weintraub FN, Shou J, Rosato EF, Lucia M. Enteral
nutrition during multimodality therapy in upper gastrointestinal cancer
patients. Ann Surg.1995
;221(4):327
-338.
125.
Di Carlo V, Gianotti L, Balzano G, Zerbi A, Braga M. Complications
of pancreatic surgery and the role of perioperative nutrition. Dig
Surg.1999
;16(4):320
-326.
126.
Farreras N, Artigas V, Cardona D, Rius X, Trias M, Gonzalez JA.
Effect of early postoperative enteral immunonutrition on wound healing in
patients undergoing surgery for gastric cancer. Clin
Nutr.2005
;24(1):55
-65.
127.
Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di Carlo V.
A randomized controlled trial of preoperative oral supplementation with a
specialized diet in patients with gastrointestinal cancer.
Gastroenterology.2002
;122(7):1763
-1770.
128.
Senkal M, Zumtobel V, Bauer KH, et al. Outcome and
cost-effectiveness of perioperative enteral immunonutrition in patients
undergoing elective upper gastrointestinal tract surgery: a prospective
randomized study. Arch Surg.1999
;134(12):1309
-1316.
129.
Braga M, Gianotti L, Nespoli L, Radaelli G, Di Carlo V. Nutritional
approach in malnourished surgical patients: a prospective randomized study.
Arch Surg.2002
;137(2):174
-180.
130.
Moore FA. Effects of immune-enhancing diets on infectious morbidity
and multiple organ failure. JPEN J Parenter Enteral
Nutr. 2001;25(2 suppl): S36-S42; discussion
S42-S43.
131.
de Luis DA, Izaola O, Cuellar L, Terroba MC, Aller R. Randomized
clinical trial with an enteral arginine-enhanced formula in early postsurgical
head and neck cancer patients. Eur J Clin Nutr.2004
;58(11):1505
-1508.
132.
Morlion BJ, Stehle P, Wachtler P, et al. Total parenteral nutrition
with glutamine dipeptide after major abdominal surgery: a randomized,
double-blind, controlled study. Ann Surg.1998
;227(2):302
-308.
133.
van Bokhorst-De Van Der Schueren MA, Quak JJ, von Blomberg-van der
Flier BM, et al. Effect of perioperative nutrition, with and without arginine
supplementation, on nutritional status, immune function, postoperative
morbidity, and survival in severely malnourished head and neck cancer
patients. Am J Clin Nutr.2001
;73(2):323
-332.
134.
Thomas E, Blume K, Forman S, eds. Hematopoietic Cell
Transplantation. 2nd ed. Malden, MA: Blackwell Science;1999
.
135.
Deeg HJ, Seidel K, Bruemmer B, Pepe MS, Appelbaum FR. Impact of
patient weight on non-relapse mortality after marrow transplantation.
Bone Marrow Transplant.1995
;15(3):461
-468.
136.
McSweeney PA, Storb R. Mixed chimerism: preclinical studies and
clinical applications. Biol Blood Marrow Transplant.1999
;5(4):192
-203.
137.
Bensinger W, Buckner C. Preparative regimens. In: Thomas E, Blume
K, Forman S, eds. Hematopoietic Cell Transplantation.
Malden, MA: Blackwell Science; 1999:123
-134.
138.
Aker S, Lessen P. Nutritional support in hematological
malignancies. In: Hoffman R, Benz E, Shattil S, et al, eds.
Hematology: Basic principles and practice. 3rd ed. New
York, NY: Churchill Livingstone; 2000:1501
-1514.
139.
Lenssen P, Sherry ME, Cheney CL, et al. Prevalence of
nutrition-related problems among long-term survivors of allogeneic marrow
transplantation. J Am Diet Assoc.1990
;90(6):835
-842.
140.
Dickson TM, Kusnierz-Glaz CR, Blume KG, et al. Impact of admission
body weight and chemotherapy dose adjustment on the outcome of autologous bone
marrow transplantation. Biol Blood Marrow Transplant.1999
;5(5):299
-305.
141.
Fleming DR, Rayens MK, Garrison J. Impact of obesity on allogeneic
stem cell transplant patients: a matched case-controlled study. Am
J Med.1997
;102(3):265
-268.
142.
Morton AJ, Gooley T, Hansen JA, et al. Association between
pre-transplant interferon-alpha and outcome after unrelated donor marrow
transplantation for chronic myelogenous leukemia in chronic phase.
Blood.1998
;92(2):394
-401.
143.
Horsley P, Bauer J, Gallagher B. Poor nutritional status prior to
peripheral blood stem cell transplantation is associated with increased length
of hospital stay. Bone Marrow Transplant.2005
; 35(11):1113
-1116.
144.
Iestra JA, Fibbe WE, Zwinderman AH, van Staveren WA, Kromhout D.
Body weight recovery, eating difficulties and compliance with dietary advice
in the first year after stem cell transplantation: a prospective study.
Bone Marrow Transplant.2002
;29(5):417
-424.
145.
Layton PB, Gallucci BB, Aker SN. Nutritional assessment of
allogeneic bone marrow recipients. Cancer Nurs.1981
;4(2):127
-134.
146.
Lough M, Watkins R, Campbell M, Carr K, Burnett A, Shenkin A.
Parenteral nutrition in bone marrow transplantation. Clin
Nutr.1990
;9(2):97
-101.
147.
Roberts S, Miller J, Pineiro L, Jennings L. Total parenteral
nutrition vs oral diet in autologous hematopoietic cell transplant recipients.
Bone Marrow Transplant.2003
;32(7):715
-721.
148.
Skop A, Kolarzyk E, Skotnicki AB. Importance of parenteral
nutrition in patients undergoing hemopoietic stem cell transplantation
procedures in the autologous system. JPEN J Parenter Enteral
Nutr.2005
;29(4):241
-247.
149.
Cetin T, Arpaci F, Dere Y, et al. Total parenteral nutrition delays
platelet engraftment in patients who undergo autologous hematopoietic stem
cell transplantation. Nutrition.2002
;18(7-8):599
-603.
150.
Mulder PO, Bouman JG, Gietema JA, et al. Hyperalimentation in
autologous bone marrow transplantation for solid tumors. Comparison of total
parenteral versus partial parenteral plus enteral nutrition.
Cancer.1989
;64(10):2045
-2052.
151.
Sheean PM, Braunschweig C, Rich E. The incidence of hyperglycemia
in hematopoietic stem cell transplant recipients receiving total parenteral
nutrition: a pilot study. J Am Diet Assoc.2004
;104(9):1352
-1360.
152.
Sheean PM, Freels SA, Helton WS, Braunschweig CA. Adverse clinical
consequences of hyperglycemia from total parenteral nutrition exposure during
hematopoietic stem cell transplantation. Biol Blood Marrow
Transplant.2006
;12(6):656
-664.
153.
Charuhas PM, Fosberg KL, Bruemmer B, et al. A double-blind
randomized trial comparing outpatient parenteral nutrition with intravenous
hydration: effect on resumption of oral intake after marrow transplantation.
JPEN J Parenter Enteral Nutr.1997
;21(3):157
-161.
154.
Jonas CR, Puckett AB, Jones DP, et al. Plasma antioxidant status
after high-dose chemotherapy: a randomized trial of parenteral nutrition in
bone marrow transplantation patients. Am J Clin Nutr.2000
;72(1):181
-189.
155.
Weisdorf SA, Lysne J, Wind D, et al. Positive effect of
prophylactic total parenteral nutrition on long-term outcome of bone marrow
transplantation. Transplantation.1987
;43(6):833
-838.
156.
Geibig CB, Owens JP, Mirtallo JM, Bowers D, Nahikian-Nelms M,
Tutschka P. Parenteral nutrition for marrow transplant recipients: evaluation
of an increased nitrogen dose. JPEN J Parenter Enteral
Nutr.1991
;15(2):184
-188.
157.
Muscaritoli M, Conversano L, Torelli GF, et al. Clinical and
metabolic effects of different parenteral nutrition regimens in patients
undergoing allogeneic bone marrow transplantation.
Transplantation.1998
;66(5):610
-616.
158.
Szeluga DJ, Stuart RK, Brookmeyer R, Utermohlen V, Santos GW.
Nutritional support of bone marrow transplant recipients: a prospective,
randomized clinical trial comparing total parenteral nutrition to an enteral
feeding program. Cancer Res.1987
;47(12):3309
-3316.
159.
Sefcick A, Anderton D, Byrne JL, Teahon K, Russell NH. Naso-jejunal
feeding in allogeneic bone marrow transplant recipients: results of a pilot
study. Bone Marrow Transplant.2001
;28(12):1135
-1139.
160.
Seguy D, Berthon C, Micol JB, et al. Enteral feeding and early
outcomes of patients undergoing allogeneic stem cell transplantation following
myeloablative conditioning. Transplantation.2006
;82(6):835
-839.
Anderson PM, Ramsay NK, Shu XO, et al. Effect of low-dose oral
glutamine on painful stomatitis during bone marrow transplantation.
Bone Marrow Transplant.1998
;22(4):339
-344.
163.
Coghlin Dickson TM, Wong RM, offrin RS, et al. Effect of oral
glutamine supplementation during bone marrow transplantation. JPEN
J Parenter Enteral Nutr.2000
;24(2):61
-66.
164.
Jebb SA, Marcus R, Elia M. A pilot study of oral glutamine
supplementation in patients receiving bone marrow transplants. Clin
Nutr.1995
;14(3):162
-165.
165.
Schloerb PR, Skikne BS. Oral and parenteral glutamine in bone
marrow transplantation: a randomized, double-blind study. JPEN J
Parenter Enteral Nutr.1999
;23(3):117
-122.
166.
Piccirillo N, De Matteis S, Laurenti L, et al. Glutamine-enriched
parenteral nutrition after autologous peripheral blood stem cell
transplantation: effects on immune reconstitution and mucositis.
Haematologica.2003
;88(2):192
-200.
167.
Pytlik R, Benes P, Patorkova M, et al. Standardized parenteral
alanyl-glutamine dipeptide supplementation is not beneficial in autologous
transplant patients: a randomized, double-blind, placebo controlled study.
Bone Marrow Transplant.2002
;30(12):953
-961.
168.
Scheid C, Hermann K, Kremer G, et al. Randomized, double-blind,
controlled study of glycyl-glutamine-dipeptide in the parenteral nutrition of
patients with acute leukemia undergoing intensive chemotherapy.
Nutrition.2004
;20(3):249
-254.
169.
Schloerb PR, Amare M. Total parenteral nutrition with glutamine in
bone marrow transplantation and other clinical applications (a randomized,
double-blind study). JPEN J Parenter Enteral Nutr.1993
;17(5):407
-413.
170.
Sykorova A, Horacek J, Zak P, Kmonicek M, Bukac J, Maly J. A
randomized, double blind comparative study of prophylactic parenteral
nutritional support with or without glutamine in autologous stem cell
transplantation for hematological malignancies—three years' follow-up.
Neoplasma.2005
;52(6):476
-482.
171.
Young LS, Bye R, Scheltinga M, Ziegler TR, Jacobs DO, Wilmore DW.
Patients receiving glutamine-supplemented intravenous feedings report an
improvement in mood. JPEN J Parenter Enteral Nutr.1993
;17(5):422
-427.
172.
Ziegler TR, Young LS, Benfell K, et al. Clinical and metabolic
efficacy of glutamine-supplemented parenteral nutrition after bone marrow
transplantation. A randomized, double-blind, controlled study. Ann
Intern Med.1992
;116(10):821
-828.
173.
Murray SM, Pindoria S. Nutrition support for bone marrow transplant
patients. Cochrane Database Syst Rev.2009
(1):CD002920
.
174.
Bodey GP, Hart J, Freireich EJ, Frei E III. Studies of a patient
isolator unit and prophylactic antibiotics in cancer chemotherapy. General
techniques and preliminary results. Cancer.1968
;22(5):1018
-1026.
175.
Bodey GP, Loftis J, Bowen E. Protected environment for cancer
patients: effect of a prophylactic antibiotic regimen on the microbial flora
of patients undergoing cancer chemotherapy. Arch Intern
Med.1968
;122(1):23
-30.
176.
Dietrich M, Gaus W, Vossen J, van der Waaij D, Wendt F. Protective
isolation and antimicrobial decontamination in patients with high
susceptibility to infection: a prospective cooperative study of gnotobiotic
care in acute leukemia patients. I: clinical results.
Infection.1977
;5(2):107
-114.
177.
Levine AS, Siegel SE, Schreiber AD, et al. Protected environments
and prophylactic antibiotics: a prospective controlled study of their utility
in the therapy of acute leukemia. N Engl J Med.1973
; 288(10):477
-483.
178.
Levitan AA, Perry S. Infectious complications of chemotherapy in a
protected environment. N Engl J Med.1967
;276(16):881
-886.
179.
Moody K, Charlson ME, Finlay J. The neutropenic diet: what's the
evidence? J Pediatr Hematol Oncol.2002
;24(9):717
-721.
180.
Yates JW, Holland JF. A controlled study of isolation and
endogenous microbial suppression in acute myelocytic leukemia patients.
Cancer.1973
;32(6):1490
-1498.
181.
Smith LH, Besser SG. Dietary restrictions for patients with
neutropenia: a survey of institutional practices. Oncol Nurs
Forum.2000
;27(3):515
-520.
182.
Moody K, Finlay J, Mancuso C, Charlson M. Feasibility and safety of
a pilot randomized trial of infection rate: neutropenic diet versus standard
food safety guidelines. J Pediatr Hematol Oncol.2006
; 28(3):126
-133.
183.
Gardner A, Mattiuzzi G, Faderl S, et al. Randomized comparison of
cooked and noncooked diets in patients undergoing remission induction therapy
for acute myeloid leukemia. J Clin Oncol.2008
;26(35):5684
-5688.
184.
Cheney CL, Weiss NS, Fisher LD, Sanders JE, Davis S,
Worthington-Roberts B. Oral protein intake and the risk of acute
graft-versus-host disease after allogeneic marrow transplantation.
Bone Marrow Transplant.1991
;8(3):203
-210.